Barry
Senior Member (Voting Rights)
Thanks @Trish, yes I'd forgotten that. Very, very good.You're right, @Barry.
We pointed all this out to Cochrane in our letter on harms sent on 17th March 2024.
And still we wait.
Thanks @Trish, yes I'd forgotten that. Very, very good.You're right, @Barry.
We pointed all this out to Cochrane in our letter on harms sent on 17th March 2024.
And still we wait.
trishrhymes
November 10, 2024 at 6:02 am
Your comment is awaiting moderation.
Hello Hilda,
Given that I already have 3 post awaiting your moderation decision, and nothing has been posted here for 3 months, I have no idea whether this page is still functioning.
However, …
Exactly a year ago you posted your first update for over 2 years on the Cochrane website:
https://community.cochrane.org/orga…older-engagement-high-profile-reviews-pilot-3
Among other things, you said:
As completing the review will take time, the joint Cochrane/IAG meeting discussed a proposal from a member of the IAG for adding a revised editorial note. Some uses of the Cochrane review do not reflect critical nuance and limitations in its conclusions, and the goal of a note would be to try to reduce such misinterpretation. There was unanimous agreement to this step, and the IAG has begun drafting a proposal for the editors’ consideration.
Is this going to happen?
You also said:
The first draft of the protocol is currently with the Cochrane Editorial Unit, and the editors are planning the next steps for the project. Once they sign off on a protocol, the IAG will be reviewing it. Then it will go to peer reviewers, some of whom will be proposed by the IAG. Responses to peer review will also be considered by the IAG.
It will be the version after all that review that will be released as a preprint. We will use our experience with the first consultation to seek, analyse, and report on feedback to the protocol. The consultation period is currently planned to be six weeks after the preprint of the protocol is released. Providing written comments won’t be the only mechanism for discussing the protocol, and we’ll let you know about other opportunities.
Please can you tell us what stage that process has reached.
In your report on 20th December 2023
https://community.cochrane.org/orga…older-engagement-high-profile-reviews-pilot-4
you said:
The revised editorial structure to support this review has taken shape. I expect details will be finalised by my next report, including a preliminary timetable.
We also plan to get the IAG’s first consultation underway in the early weeks of the new year.
Please could you tell us why this hasn’t happened.
On complaints, you said there is a new structure for handling complaints, and added:
We agreed on pathways for referring complaints, along with continuing liaison. This should improve responsiveness in future.
I recognise the handling of complaints is not your direct responsibility, but you may be able to tell us more about what is happening with S4ME’s complaints. All we’ve heard from Cochrane is that they still haven’t finished considering our complaints. No idea of timescale, nor of which complaints they are considering.
Can you share any news on the S4ME complaints?
And finally…
When do you envisage the new review will be published?
Thank you,
Trish Davis
Feel free to move if this is wrong thread.
From Todd Davenport on Bluesky:
The author team received word today that Cochrane will not accept the protocol we submitted to update the 2017 review on exercise therapy for ME/CFS. To say the very least—a disappointing development for people living with ME/CFS and the state of the science.
https://bsky.app/profile/sunsopeningband.bsky.social/post/3ldg2gcofh22d
Will the IAG have been involved in the decision to reject the new protocol?
Following committee agreement with support from a vote by voting members, the following letter has been sent by email to the members of the Cochrane ME/CFS Independent Advisory Group:
Dear [IAG member]
We are writing to you on behalf of the committee and members of the Science for ME international forum. Following concerns raised on the forum, we’re contacting you in your capacity as a member of the Cochrane ME/CFS Independent Advisory Group to ask you to call for the immediate removal of the Larun et al. 2019 Cochrane review ‘Exercise therapy for chronic fatigue syndrome’ and all earlier versions.
As you will know, the review concluded, ‘Exercise therapy probably has a positive effect on fatigue in adults with CFS compared to usual care or passive therapies. The evidence regarding adverse effects is uncertain.’ But critics immediately pointed out serious problems with the review’s methods and the low quality of the studies involved, and Cochrane’s editor-in-chief promised a new review with new methodology. Cochrane said it would commission a new review for completion within two years.
In August 2023, after four years with no sign of a new review, our Science for ME committee wrote to Cochrane asking them to withdraw the Larun et al. review. Our letter was supported by over 70 organisations and the accompanying petition by over 12,600 people, but Cochrane did not address our request and did not take down the review.
Since the review was published, government organisations such as the UK's NICE and the USA's CDC have carried out unbiased reviews showing no evidence that exercise therapy is effective for ME/CFS, and there have been widespread reports of people with ME/CFS becoming much more sick and disabled after graded exercise therapy. Science for ME wrote to Cochrane about this evidence on harms in March 2024, but had no response.
While the Larun et al. review still stands, it is influencing clinical practice worldwide, with serious risk of harm to people with ME/CFS. Cochrane seem to think that the weak review should stay in place until another Cochrane review replaces it, no matter how many years that takes or how many patients’ lives are ruined by the potentially dangerous therapy that it supports.
We don’t. This is why we are asking you, and all IAG members, to call on Cochrane to remove the Larun et al. 2019 review and all its earlier versions immediately. Cochrane have been deaf to the thousands of patients outside their organisation: but they might listen to you. We hope you will take action.
Yours sincerely,
Peter Trewhitt and Trish Davis on behalf of the members and committee of the Science for ME international forum
Did that just go today?Quoting from the letters thread:
A couple of days ago. A bit later than planned due to health etc.Did that just go today?
Here's the email from Cochrane
View attachment 24515